Anticompetitive Abuse of the Orphan Drug Act [electronic resource] : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992
- Corporate Author
- United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights
- Published
- Washington : U.S. G.P.O., 1992.
- Physical Description
- iv, 319 pages : illustrations ; 24 cm.
Access Online
- Series
- Report Numbers
- Y 4.J 89/2:S.hrg.102-615
Serial no. J-102-48 (United States. Congress. Senate. Committee on the Judiciary) - Subject(s)
- Related Titles
- ProQuest U.S. Congressional Hearings Digital Collection
- Note
- Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
AVAILABLE ONLINE TO AUTHORIZED PSU USERS. - Bibliography Note
- Includes bibliographical references.
- Reproduction Note
- Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
- Technical Details
- System requirements: PDF reader software.
- Action Note
- committed to retain. Federal Depository Library Program (FDLP). For information on our retention commitment, please contact Microforms and Government Information.
View MARC record | catkey: 9985592